Form 4 for ONC BeOne Medicines Ltd.

Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0001651308-25-000139 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-09-09	2025-09-05	ONC	Sanders Corazon (Corsee) D.	Dir	S - Sale+OE	$337.00	-2,665	0	-100%	-$898.1K
D	2025-09-09	2025-09-05	ONC	Sanders Corazon (Corsee) D.	Dir	M - OptEx	$155.68	+2,665	2,665	New	+$414.9K
D	2025-09-09	2025-09-05	ONC	Sanders Corazon (Corsee) D.	Dir	M - OptEx	$0.00	-34.6K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	American Depositary Shares	2025-09-05	S	D	2,665	$337.00	0	D	—	—	(F1) Each American Depositary Share represents 13 Ordinary Shares.
2	Common	American Depositary Shares	2025-09-05	M	A	2,665	$155.68	2,665	D	—	—	(F1) Each American Depositary Share represents 13 Ordinary Shares.
3	Derivative	Share Option (Right to Buy)	2025-09-05	M	D	34,645	$0.00	0	D	$11.98 · — to 2032-06-21	34,645 Ordinary Shares	(F2) The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. (F3) The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors (the "Board") or otherwise ceases to serve as a director, unless the Board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.